Epigenomics AG, DE000A11QW50

Epigenomics AG, DE000A11QW50

11.04.2017 - 14:06:23

Epigenomics AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Notification of Major Holdings

1. Details of issuer Epigenomics AG Geneststraße 5 10829 Berlin Germany 2. Reason for notification   Acquisition/disposal of shares with voting rights   Acquisition/disposal of instruments   Change of breakdown of voting rights X Other reason:Voluntary group notification- restructuring of group shareholdingsin Epigenomics AG 3. Details of person subject to the notification obligation Name: City and country of registered office: Global Bio and Information Technologies Partners GP Ltd. George Town, Grand CaymanCayman Islands 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.Globetrotter (BVI) Holdings, Ltd.; BioChain Institute, Inc. 5. Date on which threshold was crossed or reached 04 Apr 2017 6. Total positions   % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer Resulting situation 9.19 % 0.0 % 9.19 % 22735260 Previous notification 9.30 % 0.0 % 9.30 % / 7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 21, 22 WpHG) ISIN absolute in %   direct (Sec. 21 WpHG) indirect (Sec. 22 WpHG) direct (Sec. 21 WpHG) indirect (Sec. 22 WpHG) DE000A11QW50 0 2088685 0 % 9.19 % Total 2088685 9.19 % b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % %     Total % b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % %       Total % 8. Information in relation to the person subject to the notification obligation  Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more) Global Bio Information Technologies Partners GP Ltd. % % % Global Bio and Information Technologies Partners L.P. % % % Team Curis Group % % % Biochain (BVI) Holdings, Ltd. % % % BioChain Institute, Inc. % % % Globetrotter (BVI) Holdings, Ltd. 5.71 % 0 % 5.71 %   Global Bio Information Technologies Partners GP Ltd. % % % Global Bio and Information Technologies Partners L.P. % % % Team Curis Group % % % Biochain (BVI) Holdings, Ltd. % % % Bio-Epi (BVI) Holdings Ltd. 3.48 % 0 % 3.48 % 9. In case of proxy voting according to Sec. 22 para. 3 WpHGDate of general meeting: Holding position after general meeting: % (equals voting rights) 10. Other explanatory remarks: 

11.04.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English

Company: Epigenomics AG Geneststraße 5 10829 Berlin

Germany Internet: www.epigenomics.com   End of News DGAP News Service

564131  11.04.2017 

@ dgap.de